Search Results - "Backmund, M."

Treatment of hepatitis C infection in injection drug users by Backmund, Markus, Meyer, Kirsten, Von Zielonka, Michael, Eichenlaub, Dieter

“…Chronic hepatitis C is the most common infectious disease among injection drug users (IDUs). Because of the allegedly poor compliance of IDUs with treatment…”
Get full text

Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care by Apelt, S M, Scherbaum, N, Gölz, J, Backmund, M, Soyka, M

“…Buprenorphine is well known in the treatment of opioid dependence. Despite a high safety profile and good tolerance buprenorphine has been subject to misuse…”
Get more information

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance by Gerlach, J.Tilman, Diepolder, Helmut M, Zachoval, Reinhart, Gruener, Norbert H, Jung, Maria-Christina, Ulsenheimer, Axel, Schraut, Winfried W, Schirren, C.albrecht, Waechtler, M, Backmund, M, Pape, Gerd R

“…Acute hepatitis C virus infection accounts for approximately 20% of cases of acute hepatitis today. The aim of this study was to define the natural course of…”
Get full text

Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users by Backmund, Markus, Meyer, Kirsten, Edlin, Brian R.

“…We followed-up 18 injection drug users for a mean of 33.8 months (range, 4–55 months) after successful treatment for hepatitis C virus (HCV) infection. Fifteen…”
Get full text

Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool, including for Post-Treatment Relapse by Lamoury, F, Soker, A, Martinez, D, Hajarizadeh, B, Cunningham, E, Bruggmann, P, Foster, G, Dalgard, O, Conway, B, Robaeys, G, Swan, T, Backmund, M, Marks, P, Grebely, J, Dore, G.J, Applegate, T.L

Get full text

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe by Marshall, A.D, Nielsen, S, Cunningham, E.B, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Flisiak, R, Foster, G, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarčuška, P, Kåberg, M, Makara, M, Maimets, M, Marinho, R, Matičič, M, Norris, S, Olafsson, S, Øvrehus, A, Pawlotsky, J.-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G.J, Lazarus, J.V, Grebely, J

Get full text

Illegal drug users and risk factors for HIV and HCV infection by Backmund, M

“…Since the beginning of the HIV-epidemic, injection drug users (IDUs) have had a high risk of acquiring an infection with HIV. Chronic hepatitis C (HCV) is the…”
Get full text

P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study by Grebely, J, Dalgard, O, Conway, B, Foster, G, Bruggmann, P, Backmund, M, Robaeys, G, Swan, T, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Weltman, M, Shaw, D, Dunlop, A, Hellard, M, Bruneau, J, Bourgeois, S, Thurnheer, C, Dore, G.J

Get full text

918 VIROLOGICAL EFFICACY OF BOCEPREVIR (BOC) AND TELAPREVIR (TVR) PLUS PEGINTERFERON alfa-2a (P)/ RIBAVIRIN (R) UNTIL WEEK 12 IN DRUG ADDICTED PATIENTS WITH GT-1 INFECTION: FIRST REAL LIFE REPORT by Weber, B, Ablasmaier-Stuetzel, B, Naumann, U, Schleehauf, D, Bachner, C, Goelz, J, Bannout, F, Isernhagen, K, Gottberg, J, Forestier, N, Buescher, K.-G, Baumgarten, A, Backmund, M, Alshuth, U, Walcher, S

Get full text

Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients by Backmund, Markus, Meyer, Kirsten, Eichenlaub, Dieter, Schütz, Christian G.

“…Up to 1999 more opioid dependent patients in Germany were substituted with codeine or dihydrocodeine (summarised as codeine) than with methadone. The current…”
Get full text

1139 PREVALENCE OF AND RISK FACTORS FOR HEPATITIS C IN INJECTION DRUG USERS (IDUS) 2005-2010 IN COMPARISON WITH 1991-1996 by Backmund, M, Meyer, K, Mayer, F, Buchner, H

Get full text

Tramadol use and dependence in chronic noncancer pain patients by Soyka, M, Backmund, M, Hasemann, S

Get more information

Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study by Wittchen, Hans-Ulrich, Apelt, Sabine M., Bühringer, Gerhard, Gastpar, Markus, Backmund, Markus, Gölz, Jörg, Kraus, Michael R., Tretter, Felix, Klotsche, Jens, Siegert, Jens, Pittrow, David, Soyka, Michael

“…Buprenorphine and methadone are the two established substitution drugs licensed in many countries for the treatment of opioid dependence. Little is known,…”
Get full text

Acute pancreatitis and pericardial effusion in Behçet's disease by Backmund, Markus, Schomerus, Peter

“…GASTROENTEROLOGY 1999;117:286…”
Get full text

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs by Robaeys, Geert, Grebely, Jason, Mauss, Stefan, Bruggmann, Phili, Moussalli, Joseph, De Gottardi, Andrea, Swan, Tracy, Arain, Amber, Kautz, Achim, Stöver, Heino, Wedemeyer, Heiner, Schaefer, Martin, Taylor, Lynn, Backmund, Markus, Dalgard, Olav, Prins, Maria, Dore, Gregory J.

“…In the developed world, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden of…”
Get full text

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe by Marshall, Alison D, Cunningham, Evan B, Nielsen, Stine, Aghemo, Alessio, Alho, Hannu, Backmund, Markus, Bruggmann, Philip, Dalgard, Olav, Seguin-Devaux, Carole, Flisiak, Robert, Foster, Graham R, Gheorghe, Liana, Goldberg, David, Goulis, Ioannis, Hickman, Matthew, Hoffmann, Patrick, Jancorienė, Ligita, Jarcuska, Peter, Kåberg, Martin, Kostrikis, Leondios G, Makara, Mihály, Maimets, Matti, Marinho, Rui Tato, Matičič, Mojca, Norris, Suzanne, Ólafsson, Sigurður, Øvrehus, Anne, Pawlotsky, Jean-Michel, Pocock, James, Robaeys, Geert, Roncero, Carlos, Simonova, Marieta, Sperl, Jan, Tait, Michele, Tolmane, Ieva, Tomaselli, Stefan, van der Valk, Marc, Vince, Adriana, Dore, Gregory J, Lazarus, Jeffrey V, Grebely, Jason

“…All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have response rates of 95% or more, represent a major clinical advance. However, the…”
Get more information

Nociceptive Flexion Reflex Threshold is No Suitable Marker for Diagnosing Opioid-Induced Hyperalgesia by Trübenbacher, Luisa, Lindenberg, Nicole, Graf, Bernhard M, Backmund, Markus, Unglaub, Wilhelm, Lassen, Christoph L

“…Opioid induced hyperalgesia (OIH) describes a state of altered pain sensation due to opioid exposure. It often occurs among persons with opioid use disorder…”
Get full text

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? by Schaefer, Martin, Heinz, Andreas, Backmund, Markus

“…ABSTRACT Aims  Approximately 170 million people world‐wide are chronically infected with the hepatitis C virus (HCV). While the seroprevalence in the general…”
Get full text

Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial by Backmund, M, Meyer, K, Rothenhaeusler, H B, Soyka, M

Get full text

FRI-195 - Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool, including for Post-Treatment Relapse by Lamoury, F., Soker, A., Martinez, D., Hajarizadeh, B., Cunningham, E., Bruggmann, P., Foster, G., Dalgard, O., Conway, B., Robaeys, G., Swan, T., Backmund, M., Marks, P., Grebely, J., Dore, G.J., Applegate, T.L.

Get full text